Evidence map›Paper›PMID 38374377›Full record

ArticleScientific reports2024

Retinal vessel caliber and cognitive performance: the multi-ethnic study of atherosclerosis (MESA).

Nada El Husseini, Christopher L Schaich, Suzanne Craft, Stephen R Rapp, Kathleen M Hayden, Richey Sharrett, Mary Frances Cotch, Tien Y Wong, Jose A Luchsinger, Mark A Espeland and 3 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Retinal vasculometry associations with cognition status in UK Biobank.Alzheimer's & dementia (Amsterdam, Netherlands)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Nada El HusseiniDepartment of Neurology, Duke University Medical Center, Duke South, Purple Zone, Suite 0109, Durham, NC, 27710, USA. nada.elhusseini@duke.edu.
Christopher L SchaichDepartment of Surgery, Hypertension and Vascular Research Center, Wake Forest University School of Medicine, Winston Salem, NC, USA.
Suzanne CraftGerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston Salem, NC, USA.
Stephen R RappPsychiatry and Behavioral Medicine, Wake Forest University School of Medicine, Winston Salem, NC, USA.
Kathleen M HaydenSocial Sciences and Health Policy, Wake Forest University School of Medicine, Winston Salem, NC, USA.
Richey SharrettDepartment of Epidemiology, Johns Hopkins University, Baltimore, MD, USA.
Mary Frances CotchNational Eye Institute (NIH), Bethesda, MD, USA.
Tien Y WongDepartment of Ophthalmology and Visual Sciences, National University of Singapore, Singapore, Singapore.
Jose A LuchsingerDivision of General Medicine, Columbia University Medical Center, New York, NY, USA.
Mark A EspelandGerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston Salem, NC, USA.
Laura D BakerGerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston Salem, NC, USA.
Alain G BertoniEpidemiology and Prevention, Wake Forest University School of Medicine, Winston Salem, NC, USA.
Timothy M HughesGerontology and Geriatric Medicine, Wake Forest University School of Medicine, Winston Salem, NC, USA.

Funding

Subclinical Vascular Contributions to Alzheimer's Disease: The Multi-Ethnic Study of Atherosclerosis (MESA) Multisite Study of AD (Renewal)R01AG058969 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Timothy M. Hughes, YONGMEI LIU · 2018 to 2026
$33.4M
Wake Forest University School of Medicine Alzheimer's Disease Research CenterP30AG072947 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI SUZANNE CRAFT · 2021 to 2026
$24.3M
Midcareer Award for Research in Dementia Risk Factors and PreventionK24AG045334 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Jose Alejandro Luchsinger · 2016 to 2026
$1.5M
Multi-Ethnic Study of Atherosclerosis- Cellular Exosomes in Neurodegeneration and Dementia (MESA-CEND)R01AG068629 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI DEEP, GAGAN, HUGHES, TIMOTHY M. · 2024 to 2025
$1.5M
Cardiac Autonomic Function, Cognitive Performance, and Neurocognitive OutcomesK01AG073581 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI SCHAICH, CHRISTOPHER · 2021 to 2024
$384k
Heart Rate Variability, Cognitive Performance, and Alzheimer Disease-related Pathology in the Multi-Ethnic Study of AtherosclerosisR03AG064569 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HUGHES, TIMOTHY M., SCHAICH, CHRISTOPHER · 2019 to 2020
$155k
NIA NIH HHS K01 AG073581NIA NIH HHS K24 AG045334NIA NIH HHS P30 AG072947NIA NIH HHS R01 AG058969NIA NIH HHS R01 AG068629NIA NIH HHS R03 AG064569
6 · The paper itself

Abstract

Retinal vessel calibers share anatomic and physiologic characteristics with the cerebral vasculature and can be visualized noninvasively. In light of the known microvascular contributions to brain health and cognitive function, we aimed to determine if, in a community based-study, retinal vessel calibers and change in caliber over 8 years are associated with cognitive function or trajectory. Participants in the Multi-Ethnic Study of Atherosclerosis (MESA) cohort who completed cognitive testing at Exam 5 (2010-2012) and had retinal vascular caliber measurements (Central Retinal Artery and Vein Equivalents; CRAE and CRVE) at Exam 2 (2002-2004) and Exam 5 were included. Using multivariable linear regression, we evaluated the association of CRAE and CRVE from Exam 2 and Exam 5 and their change between the two exams with scores on tests of global cognitive function (Cognitive Abilities Screening Instrument; CASI), processing speed (Digit Symbol Coding; DSC) and working memory (Digit Span; DS) at Exam 5 and with subsequent change in cognitive scores between Exam 5 and Exam 6 (2016-2018).The main effects are reported as the difference in cognitive test score per SD increment in retinal vascular caliber with 95% confidence intervals (CI). A total of 4334 participants (aged 61.6 ± 9.2 years; 53% female; 41% White) completed cognitive testing and at least one retinal assessment. On multivariable analysis, a 1 SD larger CRAE at exam 5 was associated with a lower concomitant CASI score (- 0.24, 95% CI - 0.46, - 0.02). A 1 SD larger CRVE at exam 2 was associated with a lower subsequent CASI score (- 0.23, 95%CI - 0.45, - 0.01). A 1 SD larger CRVE at exam 2 or 5 was associated with a lower DSC score [(- 0.56, 95% CI - 1.02, - 0.09) and - 0.55 (95% CI - 1.03, - 0.07) respectively]. The magnitude of the associations was relatively small (2.8-3.1% of SD). No significant associations were found between retinal vessel calibers at Exam 2 and 5 with the subsequent score trajectory of cognitive tests performance over an average of 6 years. Wider retinal venular caliber was associated with concomitant and future measures of slower processing speed but not with later cognitive trajectory. Future studies should evaluate the utility of these measures in risk stratification models from a clinical perspective as well as for screening on a population level.

Indexed as

AtherosclerosisRetinal ArteryCognitionFemaleHumansMaleRetinaRetinal VesselsRisk Factors

Identifiers

PMID38374377
PMCPMC10876697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.